Saxenda® (liraglutide 3 mg) is a once-daily injectable treatment licensed for weight management in adults who are overweight or obese. It works by mimicking the natural hormone GLP-1, helping regulate appetite, increase feelings of fullness, and reduce hunger—supporting sustainable weight loss when combined with lifestyle changes.
Saxenda acts on the appetite-control centres of the brain to:
Reduce hunger and cravings
Slow stomach emptying to help you feel fuller for longer
Support healthier eating habits
Reduce overall daily calorie intake
To improve tolerability, Saxenda is increased gradually:
Week 1: 0.6 mg once daily
Week 2: 1.2 mg once daily
Week 3: 1.8 mg once daily
Week 4: 2.4 mg once daily
Week 5 onwards (maintenance): 3.0 mg once daily
Clinical trials show that patients using Saxenda with diet and exercise achieved:
Up to 8–10% average body-weight loss over 56 weeks
Significantly greater weight loss compared to lifestyle changes alone
Many patients begin to notice appetite reduction within the first few weeks
Saxenda may be suitable for adults who:
Have a BMI ≥30, or
Have a BMI ≥27 with a weight-related health condition (e.g., high blood pressure, high cholesterol, prediabetes)
Saxenda is also an option for individuals who prefer a daily injection rather than a weekly treatment.
Proven weight loss when paired with lifestyle changes
Daily dose allows steady, predictable appetite control
Helps reduce food cravings and improve portion control
FDA and MHRA approved for long-term weight management
